Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37455 | 57 | 32.5 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
607 | 3 | BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//CYTOTECHNOLOGY | 14212 |
3451 | 2 | HUMAN HUMAN HYBRIDOMA//IMMUNOGLOBULIN PRODUCTION STIMULATING FACTOR//HYBRIDOMA | 1523 |
37455 | 1 | ACYLATED POLYMERIZED POLYSACCHARIDES//CATIONIC 80 NM BIOVECTORS//HAEMOLYTIC CH50 TEST | 57 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACYLATED POLYMERIZED POLYSACCHARIDES | authKW | 535714 | 2% | 100% | 1 |
2 | CATIONIC 80 NM BIOVECTORS | authKW | 535714 | 2% | 100% | 1 |
3 | HAEMOLYTIC CH50 TEST | authKW | 535714 | 2% | 100% | 1 |
4 | IE1 PROTEIN | authKW | 535714 | 2% | 100% | 1 |
5 | IFR 114EA 4483 | address | 535714 | 2% | 100% | 1 |
6 | IFR PHYS 114 | address | 535714 | 2% | 100% | 1 |
7 | LIPID SUGAR INTERACTION | authKW | 535714 | 2% | 100% | 1 |
8 | MEDEA 4483IFR 114 | address | 535714 | 2% | 100% | 1 |
9 | MULLERIAN DUCT AND WOLFFIAN DUCT | authKW | 535714 | 2% | 100% | 1 |
10 | SOFT ELECTROPHORESIS | authKW | 535714 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 791 | 44% | 0% | 25 |
2 | Engineering, Chemical | 40 | 12% | 0% | 7 |
3 | Chemistry, Multidisciplinary | 24 | 16% | 0% | 9 |
4 | Materials Science, Biomaterials | 22 | 4% | 0% | 2 |
5 | Pharmacology & Pharmacy | 16 | 12% | 0% | 7 |
6 | Medical Informatics | 10 | 2% | 0% | 1 |
7 | Engineering, Biomedical | 8 | 4% | 0% | 2 |
8 | Literature | 8 | 2% | 0% | 1 |
9 | Biophysics | 8 | 5% | 0% | 3 |
10 | Anatomy & Morphology | 8 | 2% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IFR 114EA 4483 | 535714 | 2% | 100% | 1 |
2 | IFR PHYS 114 | 535714 | 2% | 100% | 1 |
3 | MEDEA 4483IFR 114 | 535714 | 2% | 100% | 1 |
4 | IMPRTIFR 114 | 267856 | 2% | 50% | 1 |
5 | TOXICOL ST PUBL ENVIRONM | 267856 | 2% | 50% | 1 |
6 | MED POLE RECH | 54941 | 4% | 5% | 2 |
7 | BIOL MOL SEQUENCAGE | 53570 | 2% | 10% | 1 |
8 | UPR 9026 | 24349 | 2% | 5% | 1 |
9 | WELLCOME S | 24349 | 2% | 5% | 1 |
10 | EA4483 | 14879 | 2% | 3% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | M S-MEDECINE SCIENCES | 78007 | 39% | 1% | 22 |
2 | CHEMICAL & ENGINEERING NEWS | 6595 | 12% | 0% | 7 |
3 | ANTIBIOTIKI I KHIMIOTERAPIYA | 912 | 2% | 0% | 1 |
4 | EXPLICATOR | 815 | 2% | 0% | 1 |
5 | CANADIAN JOURNAL OF GASTROENTEROLOGY | 410 | 2% | 0% | 1 |
6 | BIOFUTUR | 324 | 2% | 0% | 1 |
7 | FARMACO | 304 | 2% | 0% | 1 |
8 | PHARMACEUTICAL RESEARCH | 265 | 4% | 0% | 2 |
9 | MOUNT SINAI JOURNAL OF MEDICINE | 240 | 2% | 0% | 1 |
10 | RECHERCHE | 225 | 2% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DE MIGUEL, I , IMBERTIE, L , RIEUMAJOU, V , MAJOR, M , KRAVTZOFF, R , BETBEDER, D , (2000) PROOFS OF THE STRUCTURE OF LIPID COATED NANOPARTICLES (SMBV (TM)) USED AS DRUG CARRIERS.PHARMACEUTICAL RESEARCH. VOL. 17. ISSUE 7. P. 817-824 | 5 | 29% | 45 |
2 | RUFFIE, J , (1996) BLOOD TRANSFUSION HISTORY.M S-MEDECINE SCIENCES. VOL. 12. ISSUE 12. P. 1402-1404 | 3 | 60% | 0 |
3 | VON HOEGEN, P , (2001) SYNTHETIC BIOMIMETIC SUPRA MOLECULAR BIOVECTOR (TM) (SMBV (TM)) PARTICLES FOR NASAL VACCINE DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 51. ISSUE 1-3. P. 113-125 | 6 | 21% | 24 |
4 | DOMBU, C , CARPENTIER, R , BETBEDER, D , (2012) INFLUENCE OF SURFACE CHARGE AND INNER COMPOSITION OF NANOPARTICLES ON INTRACELLULAR DELIVERY OF PROTEINS IN AIRWAY EPITHELIAL CELLS.BIOMATERIALS. VOL. 33. ISSUE 35. P. 9117 -9126 | 4 | 22% | 5 |
5 | GOUD, B , TIXIERVIDAL, A , (1995) THE INTRACELLULAR WANDERING OF PROTEINS.RECHERCHE. VOL. 26. ISSUE 274. P. 254-260 | 2 | 67% | 0 |
6 | DODET, B , DETHE, G , (1996) COMPARATIVE APPROACH TO RETROVIRAL VACCINES.M S-MEDECINE SCIENCES. VOL. 12. ISSUE 1. P. 87-93 | 4 | 31% | 0 |
7 | MERHI, M , DOMBU, CY , BRIENT, A , CHANG, J , PLATEL, A , LE CURIEUX, F , MARZIN, D , NESSLANY, F , BETBEDER, D , (2012) STUDY OF SERUM INTERACTION WITH A CATIONIC NANOPARTICLE: IMPLICATIONS FOR IN VITRO ENDOCYTOSIS, CYTOTOXICITY AND GENOTOXICITY.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 423. ISSUE 1. P. 37-44 | 4 | 11% | 25 |
8 | DOMBU, CY , KROUBI, M , ZIBOUCHE, R , MATRAN, R , BETBEDER, D , (2010) CHARACTERIZATION OF ENDOCYTOSIS AND EXOCYTOSIS OF CATIONIC NANOPARTICLES IN AIRWAY EPITHELIUM CELLS.NANOTECHNOLOGY. VOL. 21. ISSUE 35. P. - | 4 | 11% | 32 |
9 | SIGUIER, JP , MAJOR, M , BALLAND, O , (2002) DEVELOPMENT OF A NEW METHOD TO CHARACTERIZE (SMBV (TM)) ANTIGEN FORMULATIONS USING SURFACE PLASMON RESONANCE TECHNOLOGY.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 242. ISSUE 1-2. P. 411-415 | 2 | 25% | 4 |
10 | POENARU, L , (1996) GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES.M S-MEDECINE SCIENCES. VOL. 12. ISSUE 1. P. 35-46 | 5 | 12% | 8 |
Classes with closest relation at Level 1 |